NIH-AARP 饮食与健康研究中黑人与白人男性前列腺癌危险因素
基于 NIH-AARP 饮食与健康研究的前瞻性队列,在黑人男性 1417 例(晚期 209 例)与白人男性 28845 例(晚期 3898 例)中比较前列腺癌危险因素的种族特异性关联,采用 Cox 比例风险回归估计 HR 与 95%CI。结果显示仅糖尿病病史在黑白人中关联相似,身高与维生素 D 摄入存在种族交互,逐项校正后黑人种族 HR 累积升高。
要点
- 糖尿病病史与前列腺癌风险呈负相关,黑人与白人男性关联相似(Pinteraction=0.66)。
- 身高与前列腺癌风险的关联存在种族差异,白人正向、黑人反向(非晚期 Pinteraction=0.01)。
- 逐项校正各因素后黑人种族 HR 累积升高,总体癌增加 32.9%、晚期癌增加 12.4%。
核心结论
- 在主要为非西班牙裔白人男性中发现的饮食、营养素与健康相关因素,多数在黑人男性中未显示与前列腺癌风险的关联。
- 校正这些因素后黑人白人之间的风险差异反而扩大,提示需要更大规模的黑人男性前瞻性研究识别其特有危险因素。
研究设计与样本
- NIH-AARP 饮食与健康研究的前瞻性队列分析,采用 Cox 比例风险回归模型估计 HR 与 95%CI。
- 黑人男性 1417 例前列腺癌(其中晚期 209 例),白人男性 28845 例(其中晚期 3898 例)。
主要发现
- 糖尿病病史与总体前列腺癌风险呈负相关,黑人 HR=0.77(95%CI 0.65-0.90),白人 HR=0.72(95%CI 0.69-0.76),Pinteraction=0.66。
- 身高与前列腺癌风险的关联在种族间存在交互:非晚期 Pinteraction=0.01,晚期 Pinteraction=0.04。
- 身高交互在随访至少 2 年的非晚期病例中仍存在(Pinteraction=0.01),但晚期病例中不存在(Pinteraction=0.24)。
- 校正前列腺癌筛查后身高交互不再显著:非晚期 Pinteraction=0.53,晚期 Pinteraction=0.31。
- 饮食维生素 D 摄入与非晚期疾病的种族交互仅在校正筛查后出现(Pinteraction=0.02)。
关键数值与推荐
- 糖尿病病史:黑人 HR=0.77(95%CI 0.65-0.90),白人 HR=0.72(95%CI 0.69-0.76),Pinteraction=0.66。
- 身高交互:非晚期 Pinteraction=0.01,晚期 Pinteraction=0.04;随访≥2 年非晚期 Pinteraction=0.01,晚期 Pinteraction=0.24。
- 校正筛查后身高交互:非晚期 Pinteraction=0.53,晚期 Pinteraction=0.31。
- 维生素 D 摄入与非晚期疾病交互(校正筛查后):Pinteraction=0.02。
- 逐项校正后黑人种族 HR 累积变化:总体癌增加 32.9%,晚期癌增加 12.4%。
临床怎么用
- 糖尿病病史可作为黑人及白人男性前列腺癌风险分层时参考的负相关因素。
- 身高与前列腺癌风险的种族差异受筛查行为影响,解读时需考虑筛查校正。
- 现有主要基于白人男性的饮食与营养素危险因素不宜直接外推至黑人男性。
局限性
- 黑人男性病例数相对较少(1417 例,晚期 209 例),限制种族特异性关联的统计效能。
- 研究以非西班牙裔白人为主,黑人男性样本代表性有限。
- 身高与维生素 D 摄入的种族交互在部分分析中受筛查校正影响而不稳健。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are few prospective studies comparing race-specific associations between diet, nutrients, and health-related parameters, and prostate cancer risk. METHODS: Race-specific prostate cancer risk associations were examined among men in the National Institutes of Health (NIH)-AARP Diet and Health Study. We identified 1417 cases among black men (209 advanced), and 28,845 among white men (3898 advanced). Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs). We also evaluated the cumulative change in the HR for black race following adjustment for each factor. RESULTS: Race-specific prostate cancer associations were similar in black and white men across disease subtypes only for history of diabetes (overall : HR = 0.77, 95% CI: 0.65-0.90 and HR = 0.72, 95% CI: 0.69-0.76, respectively; Pinteraction = 0.66). By contrast, there was a positive risk association with height for white men and inverse for black men (Pinteraction: non-advanced = 0.01; advanced = 0.04). This difference remained among men with at least 2 years of follow-up for non-advanced (Pinteraction = 0.01), but not advanced disease (Pinteraction = 0.24); or after adjustment for prostate cancer screening (non-advanced Pinteraction = 0.53, advanced Pinteraction = 0.31). The only other evidence of interaction with race was observed for dietary vitamin D intake and non-advanced disease, but only after adjustment for screening (Pinteraction = 0.02). Cumulative adjustment for each factor increased the HR for black race by 32.9% for overall cancer and 12.4% for advanced disease. CONCLUSIONS: Our data suggest few of the dietary, nutrient, and health-related factors associated with prostate cancer risk in predominantly non-Hispanic white men were associated with risk in black men, and adjustment for these factors widen the black-white difference in risk. Larger studies of black men, particularly with prospective data, are needed to help identify risk factors relevant to this population.
引用
- Layne TM, Graubard BI, Ma X, et al. Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study. Prostate Cancer Prostatic Dis. 2018. PMID: 30108373. doi:10.1038/s41391-018-0070-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。